Cancer Immunotherapy and Biomarkers

82 ta ish

1. Analysis of cancer incidence structure in the Republic of Uzbekistan

   Mirzagaleb Tillyashaykhov, Sayde Djanklich, S. N. Ibragimov +1

   MaqolaEsophageal Cancer Research and TreatmentOncologia i radiologia Kazakhstana20214 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.398612

2. Changes In Tumor Infiltrating Lymphocytes Of Peripheral Blood And Tissue During Chemotherapy In Patients With Gastric Cancer

   G. G. Khakimova, G.A. Khakimov Khakimov, Shakhnoz G. Khakimova +2

   MaqolaGastric Cancer Management and OutcomesThe American Journal of Medical Sciences and Pharmaceutical Research20211 iqtibos

   ABIABI:AkademIndex/openalex/2021.article.002632

3. QANDLI DIABET KASALLIGINI DAVOLASHDA ISHLATILADIGAN O’SIMLIKLARNING KIMYOVIY TARKIBI

   Ibrohimjon Rahmonovich Asqarov, Dlafruz Valijon qizi G’aniyeva, Obidjon Shaxabidinovich Abdulloyev

   MaqolaEducation, Innovation and Language StudiesJournal of Chemistry of Goods and Traditional Medicine20221 iqtibos

   ABIABI:AkademIndex/openalex/2022.article.002171

4. Artificial intelligence for chimeric antigen receptor-based therapies: a comprehensive review of current applications and future perspectives

   Muqadas Shahzadi, Hamad Rafique, Ahmad Waheed +4

   Sharh maqolaCAR-T cell therapy researchTherapeutic Advances in Vaccines and Immunotherapy20241 iqtibos

   ABIABI:AkademIndex/openalex/2024.review-article.000014

5. The evolution of cellular-based immunotherapy in the treatment of gastric cancer: an overview of clinical trials

   Lang Wu, Jasur Rizaev, Khaled Fahmi Fawy +7

   MaqolaCAR-T cell therapy researchClinical & Translational Oncology20261 iqtibos

   ABIABI:AkademIndex/openalex/2026.article.000259

6. Investigation of erythrocytes tritium labelled glucose uptake in patients with diabetes mellutis

   Zulaykho Shamansurova, Turakulov IaKh, G.S. Akramova +5

   MaqolaSkin Diseases and Diabetes20000 iqtibos

   ABIABI:AkademIndex/openalex/2000.article.000322

7. DIAGNOSTIC VALUE OF STUDYING THE LEVELS OF PRO- AND ANTI-INFLAMMATORY CYTOKINES OF THE IMMUNE SYSTEM IN PATIENTS WITH BREAST CANCER

   L. Alimkhodjaeva

   MaqolaCancer Immunotherapy and BiomarkersDOAJ (DOAJ: Directory of Open Access Journals)20140 iqtibos

   ABIABI:AkademIndex/openalex/2014.article.000706

8. The specific features of cellular, humoral, and activation markers of the immune system and the biophysical parameters of superficial peripheral lymphocyte membranes in patients with breast cancer

   L. T. Alimkhodzhayeva, A. D. Zikiryakhodzhayev

   MaqolaImmunotherapy and Immune ResponsesDOAJ (DOAJ: Directory of Open Access Journals)20140 iqtibos

   ABIABI:AkademIndex/openalex/2014.article.000710

9. 67P Diagnostic value of immune histochemical and molecular biological parameters in younger patients with breast cancer

   L. Alimkhodjaeva, D. Nishanov, L. Zakirova

   MaqolaCancer Immunotherapy and BiomarkersAnnals of Oncology20150 iqtibos

   ABIABI:AkademIndex/openalex/2015.article.000632

10. Determination chromosome aberration as a factor of prognosis in treatment of bilateral renal cell carcinoma

    N. Rahimov, Boyko V. Elena, Valieva T. Rano +1

    MaqolaMultiple and Secondary Primary CancersAnnals of Oncology20170 iqtibos

    ABIABI:AkademIndex/openalex/2017.article.000773

11. Importance of cytokines in women with ovarian cancer

    Bakhodir Kurbanov

    MaqolaCancer Immunotherapy and BiomarkersAnnals of Oncology20170 iqtibos

    ABIABI:AkademIndex/openalex/2017.article.000804

12. Nivolumab for recurrent cutaneous squamous cell carcinoma: three cases

    Veronika Blum, Beat Müller, Silvia Höfer +7

    MaqolaCancer Immunotherapy and BiomarkersEuropean Journal of Dermatology20180 iqtibos

    ABIABI:AkademIndex/openalex/2018.article.000039

13. Clinicopathological significance of HER2 and EGFR expression in urothelial carcinoma: A single center study

    Gulrukh Botiralieva, Mirzagaleb Tillyashaykhov, A. Yusupbekov

    MaqolaBladder and Urothelial Cancer TreatmentsAnnals of Oncology20180 iqtibos

    ABIABI:AkademIndex/openalex/2018.article.000660

14. MAIN MOLECULAR-BIOLOGICAL MARKERS IN СERVICAL CANCER

    Sergey Viktorovich Kamishov

    MaqolaCancer-related molecular mechanisms researchJournal of science and education20180 iqtibos

    ABIABI:AkademIndex/openalex/2018.article.000778

15. PO-291 The disbalance of the basic cytokines of the immune system in patients with ovarian cancer on the background of immunotherapy

    S. Kamishov

    MaqolaCancer Immunotherapy and BiomarkersESMO Open20180 iqtibos

    ABIABI:AkademIndex/openalex/2018.article.000791

16. Study of cellular immunity in children and adolescents with nasopharyngeal cancer

    Nargiza Karimova, D. Polatova, A Z Ismailova +2

    MaqolaImmune Cell Function and InteractionAnnals of Oncology20180 iqtibos

    ABIABI:AkademIndex/openalex/2018.article.000903

17. MAIN MOLECULAR-BIOLOGICAL MARKERS IN СERVICAL CANCER

    Sergey Viktorovich Kamishov

    MaqolaCancer-related molecular mechanisms researchJournal of science and education20180 iqtibos

    ABIABI:AkademIndex/openalex/2018.article.001149

18. Evaluation of the effect of cholesorption on the concentration of TNF-α in the serum of the blood in tumours of the biliopancreatoduodenal zone

    M. Salokhiddinov, S. Matmuratov, E. Stamou

    MaqolaCholangiocarcinoma and Gallbladder Cancer StudiesAnnals of Oncology20190 iqtibos

    ABIABI:AkademIndex/openalex/2019.article.001527

19. Intratumoral Nanofluidic System for Enhancing Tumor Biodistribution of Agonist CD40 Antibody

    Corrine Ying Xuan Chua, Jeremy Ho, Antonia Susnjar +6

    MaqolaNanopore and Nanochannel Transport StudiesAdvanced Therapeutics20200 iqtibos

    ABIABI:AkademIndex/openalex/2020.article.000214

20. Expression, Prognosis, and Immune Infiltrates Analyses of E2F-Related Transcription Factor Family in Human Brain and CNS Cancer

    Pan Liao, Shuzhen Han, Honglan Qu

    MaqolaCancer Immunotherapy and BiomarkersSSRN Electronic Journal20200 iqtibos

    ABIABI:AkademIndex/openalex/2020.article.002176

21. DERN CONTROL POINT INHIBITORS AND THEIR POSSIBILITIES FOR THE THERAPY OF METASTATIC UROTELIAL CANCER

    M.N. Tillyashajhov, С В Камышов, E. P. Bojko

    MaqolaBladder and Urothelial Cancer TreatmentsEurasianUnionofScientists20200 iqtibos

    ABIABI:AkademIndex/openalex/2020.article.002791

22. 18P Influence of local immunity on the prognosis of gastric cancer

    Г. Р. Хакимова

    MaqolaCancer Immunotherapy and BiomarkersAnnals of Oncology20200 iqtibos

    ABIABI:AkademIndex/openalex/2020.article.003676

23. Flanvotumab

    National Cancer Institute

    BoshqaCancer Immunotherapy and BiomarkersDefinitions20200 iqtibos

    ABIABI:AkademIndex/openalex/2020.other.000087

24. Narnatumab

    National Cancer Institute

    BoshqaCancer Immunotherapy and BiomarkersDefinitions20200 iqtibos

    ABIABI:AkademIndex/openalex/2020.other.000090

25. A REVIEW OF MODERN IMMUNOTHERAPY IN GASTROINTESTINAL MALIGNANT TUMORS

    A. Yusupbekov, S.V. Kamishov, A.A. Adilkhodjaev +2

    Sharh maqolaCancer Immunotherapy and BiomarkersEurasianUnionofScientists20200 iqtibos

    ABIABI:AkademIndex/openalex/2020.review-article.000024